# Grannus Therapeutics, Inc. — Form D

Grannus Therapeutics, Inc. of INDIANAPOLIS, IN, a company, filed a Form D exempt-offering notice with the SEC on 2024-01-12. The offering totals $800K, of which $800K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-01-12
- Form: D
- Accession: 0001905806-24-000004
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $800K
- Amount sold: $800K
- Minimum investment: $250K
- Investors: 9
- Date of first sale: 2023-11-17
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-502310

## Issuer

- Name: Grannus Therapeutics, Inc.
- CIK: 0001905806
- Entity type: Corporation
- Jurisdiction: UNITED STATES
- Incorporated: 2020
- Address: 7210 N. PENNSYLVANIA STREET, INDIANAPOLIS, IN, 46240
- Phone: 3174146205

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Brian Blagg | Director | Indianapolis, IN |
| John Foglesong | Director | Indianapolis, IN |
| John Foglesong | Executive Officer | Indianapolis, IN |
| James Thompson | Director | Rushford, MN |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2022-01-21](https://search.stillhousedata.com/formd/0001905806-22-000001) | D | $1.0M | $950K |

## More

- [CIK 1905806 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1905806&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001905806-24-000004.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.